Product Information
LEUPROLIDE 2WK 14 MG/2.8 ML KT is a generic product labeled by Eugia US LLC, priced at $197.6060 per EA under NDC 55150047801. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Jun 6, 2022. Its Orange Book therapeutic-equivalence code is AP.
Manufacturer
Eugia US LLCNDC
55150047801
Classification
Generic
Dosage Form
KIT
Effective Date
5/20/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA212963FDA Approved
6/6/2022
TE Code
AP
On Market Since
6/6/2022
Price Statistics
The NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 14.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $197.6060 per EA |
|---|---|
| All-time high | $301.8717 (Sep 10, 2025) |
| All-time low | $197.6060 (May 20, 2026) |
| 52-week high | $301.8717 |
| 52-week low | $197.6060 |
| Median price | $256.3443 |
| Average price | $253.5397 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LEUPROLIDE ACETATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEUPROLIDE 2WK 14 MG/2.8 ML KT?
The current National Average Drug Acquisition Cost (NADAC) for LEUPROLIDE 2WK 14 MG/2.8 ML KT, manufactured by Eugia US LLC, is $197.6060 per EA (NDC 55150047801), effective Aug 19, 2026.
How has the price of LEUPROLIDE 2WK 14 MG/2.8 ML KT changed over time?
Over the history we have for it, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has declined 14.2%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LEUPROLIDE 2WK 14 MG/2.8 ML KT?
Since Apr 17, 2024, the NADAC for LEUPROLIDE 2WK 14 MG/2.8 ML KT has ranged from a low of $197.6060 (May 20, 2026) to a high of $301.8717 (Sep 10, 2025), with a median of $256.3443 per EA.
Are there cheaper alternatives to LEUPROLIDE 2WK 14 MG/2.8 ML KT?
No other NADAC-published product currently shares the active ingredient and strength of LEUPROLIDE 2WK 14 MG/2.8 ML KT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LEUPROLIDE 2WK 14 MG/2.8 ML KT?
LEUPROLIDE 2WK 14 MG/2.8 ML KT (NDC 55150047801) is labeled by Eugia US LLC, and CMS classifies it as a generic product.